Ex parte DOMB et al. - Page 5



                   Appeal No. 1997-2874                                                                                                                             
                   Application 08/219,160                                                                                                                           



                   It can be seen that claim 1 in the parent application and claim 1 before us are the same in all                                                  
                   respects except that the latter imposes a more severe restriction on the carboxylic acid content                                                 
                   of the claimed hydroxamic acid polymers.  That is, claim 1 before us requires that “the                                                          
                   carboxylic acid groups constitutes less than about 3 mole percent of the functional groups” of                                                   
                   the claimed hydroxamic acid polymers whereas claim 1 in the parent application required that                                                     
                   “the carboxylic acid groups constitute less than about 15% of the functional groups” of the                                                      
                   claimed hydroxamic acid polymers.  Claim 1 in the parent application was broader and,                                                            
                                                                                                                                         1                          
                   therefore, more vulnerable to a prior art rejection, compared with claim 1 before us.   As will                                                  
                   become apparent in the ensuing discussion, the claim language requiring “less than about 3                                                       
                   mole percent” carboxylic acid functional groups in applicants' hydroxamic acid polymers                                                          
                   constitutes the salient limitation in the claims before us and serves to patentably distinguish                                                  
                   over the cited prior art.                                                                                                                        
                            For a prior art reference to anticipate in terms of 35 U.S.C. § 102, every element of the                                               
                   claimed invention must be identically shown in a single reference.  Diversitech Corp. v. Century                                                 
                   Steps, Inc., 850 F.2d 675, 677, 7 USPQ2d 1315, 1317 (Fed. Cir. 1988).                                                                            
                   Here, the examiner has not established that Woodberry describes hydroxamic acid polymers                                                         
                   having “less than about 3 mole percent” of carboxylic acid functional groups, a requirement of                                                   
                   every independent claim on appeal.  The examiner does not point to any portion of Woodberry                                                      


                            1Every independent claim before us (1, 15, 18, 21, and 23) requires that                                                                
                   applicants' hydroxamic acid polymers or polymeric material have less than about 3 mole                                                           
                   percent carboxylic acid functional groups.                                                                                                       
                                                                                   5                                                                                




Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007